European Society of Toxicology In Vitro > News > ESTIV and ONTOX signs Memorandum of Understanding
29 October 2021

ESTIV and ONTOX signs Memorandum of Understanding

Scope of Collaboration

ESTIV and ONTOX entered into the MoU to jointly conduct the following activities:

  • to share appropriate information related to the activities in the field of research on NAMs to adequate target audiences
  • to jointly organise events with clear mutual benefits for ESTIV and for ONTOX.

The MoU has been signed on 19 October 2021 by ESTIV President, Dr. Helena Kandarova and ONTOX Project Coordinator, Prof. Mathieu Vinken (VUB).


ONTOX is conducting a research project in the context of the European H2020 Research and Innovation Programme SC1-BHC-11-2020 called “Advancing the safety assessment of chemicals without the use of animal testing”. The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. More at: www.ontox-project.eu

Related content

Call for late-breaking abstracts – the deadline is February 29, 2024!

  • News

Do not miss your chance to present your valuable science at the ESTIV 2024 congress in the beautiful city of Prague!

The Special Issue of ESTIV 2022 Congress has been completed

  • News

The Editorial team of the special issue ESTIV 2022: Key enabling non-animal technologies for research, education and testing – Drs. Helena Kandarova, Clive Roper and Marketa Dvořáková – are happy to share that all papers submitted in relation to the ESTIV 2022 Congress in Barcelona have been published in Toxicology in Vitro, as Virtual Special Issue.

Our vice president, Dr.Clive Roper, interviewed by Pro Anima

  • News

Comité Scientifique Pro Anima interviewed our vice-president Dr.Clive Roper. You can read this in French and English.

Silver Sponsor

Memorandum of Understanding